Abstract
In recent years, the role of tumor-initiating cells (popularly known as cancer stem cells) in tumor development and availability of novel cancer stem cell/tumor initiating cell markers promises a new arena in understanding their role in developing novel targeted molecules. It is important to identify and understand the relevance of cancer stem cells (CSC)/tumor initiating cells (TIC) in tumor development and to design appropriate strategies for CSCs and TICs elimination, which is crucial to future cancer prevention and treatment. In this review, we attempt to define various potential markers of cancer stem cells and potential exploration as therapeutic targets for epithelial cancer prevention and treatment.
Publication types
-
Research Support, N.I.H., Extramural
-
Review
MeSH terms
-
AC133 Antigen
-
Antigens, CD / genetics
-
Antigens, CD / metabolism
-
Biomarkers, Tumor / metabolism*
-
Doublecortin-Like Kinases
-
Epithelial Cells / metabolism
-
Epithelial Cells / pathology*
-
Glycoproteins / genetics
-
Glycoproteins / metabolism
-
Humans
-
Intracellular Signaling Peptides and Proteins / genetics
-
Intracellular Signaling Peptides and Proteins / metabolism
-
Neoplasms / metabolism*
-
Neoplasms / pathology
-
Neoplastic Stem Cells / metabolism*
-
Neoplastic Stem Cells / pathology
-
Nerve Tissue Proteins / genetics
-
Nerve Tissue Proteins / metabolism
-
Peptides / genetics
-
Peptides / metabolism
-
Protein Serine-Threonine Kinases / genetics
-
Protein Serine-Threonine Kinases / metabolism
-
RNA-Binding Proteins / genetics
-
RNA-Binding Proteins / metabolism
-
Receptors, G-Protein-Coupled / genetics
-
Receptors, G-Protein-Coupled / metabolism
Substances
-
AC133 Antigen
-
Antigens, CD
-
Biomarkers, Tumor
-
Glycoproteins
-
Intracellular Signaling Peptides and Proteins
-
LGR5 protein, human
-
MSI1 protein, human
-
Nerve Tissue Proteins
-
Peptides
-
RNA-Binding Proteins
-
Receptors, G-Protein-Coupled
-
DCLK1 protein, human
-
Doublecortin-Like Kinases
-
Protein Serine-Threonine Kinases